REMARK guidelines for tumour biomarker study reporting: a remarkable history.

In 2005, several experts in tumor biomarker research publishe the REporting recommendations for Tumor MARKer prognostic studies (REMARK) criteria. Coupled with the subsequent Biospecimen Reporting for Improved Study Quality (BRISQ) criteria, these initiatives provide a framework for transparently reporting of the methods of study conduct and analyses. © 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Citation

Daniel F Hayes, Willi Sauerbrei, Lisa M McShane. REMARK guidelines for tumour biomarker study reporting: a remarkable history. British journal of cancer. 2023 Feb;128(3):443-445

Mesh Tags

Substances

PMID: 36476656

search → result